Pharmacoepidemiological research of lipid-lowering therapy in ischemic heart disease
The pharmacoepidemiological study includes a review of the use of lipid-lowering drugs with the main indicators of consumption - defined daily dose (DDD) and prescribed daily dose (PDD). Pharmacoepidemiological analysis revealed that the pharmacotherapy of ischemic heart disease in a sample of patie...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2014-08-01
|
| Series: | Кубанский научный медицинский вестник |
| Subjects: | |
| Online Access: | https://ksma.elpub.ru/jour/article/view/182 |
| Summary: | The pharmacoepidemiological study includes a review of the use of lipid-lowering drugs with the main indicators of consumption - defined daily dose (DDD) and prescribed daily dose (PDD). Pharmacoepidemiological analysis revealed that the pharmacotherapy of ischemic heart disease in a sample of patients studied mainly prescribers Tulip (atorvastatin) at daily doses of 10 and 20 mg, as well Atoris (atorvastatin) in a daily dose of 10 mg. The total cost of lipid-lowering therapy in 660 patients with ischemic heart disease in 2009-2010 amounted to 440,1 thousand rubles. Applied consumption indicators showed that the maximum DDD - at tulip, PDD - at simgal and simvakard. The maximum value of DDD - at tulip, PDD - at zocor. |
|---|---|
| ISSN: | 1608-6228 2541-9544 |